Semler Scientific Inc (NASDAQ:SMLR) Director Herbert J. Semler sold 20,000 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $3.37, for a total value of $67,400.00. Following the completion of the transaction, the director now directly owns 130,000 shares in the company, valued at approximately $438,100. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Semler Scientific Inc (NASDAQ:SMLR) traded up 1.37% during trading on Friday, reaching $3.70. The company’s stock had a trading volume of 11,925 shares. Semler Scientific Inc has a 1-year low of $1.28 and a 1-year high of $3.97. The stock’s market cap is $20.21 million. The company’s 50 day moving average price is $3.39 and its 200-day moving average price is $3.00.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported ($0.16) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by ($0.05). The firm had revenue of $2.58 million during the quarter, compared to the consensus estimate of $2.23 million. Equities analysts forecast that Semler Scientific Inc will post ($0.36) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Semler Scientific Inc (SMLR) Director Herbert J. Semler Sells 20,000 Shares” was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.dailypolitical.com/2017/09/16/semler-scientific-inc-smlr-director-herbert-j-semler-sells-20000-shares.html.

Semler Scientific Company Profile

Semler Scientific, Inc develops, manufactures and markets products and services that assist healthcare insurers and physician groups in evaluating and treating chronic diseases. The Company markets QuantaFlo and WellChec to its customers. QuantaFlo is an approximately four-minute in-office blood flow test.

Receive News & Ratings for Semler Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.